Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Gastrointestinal Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03428958
What this trial is testing

A Safety, Pharmacokinetic and Efficacy Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Carcinoma+2 more
NuCana plc 111
Testing effectiveness (Phase 2)Study completedNCT03033225
What this trial is testing

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

Who this might be right for
Advanced Pancreatic CarcinomaLocally Advanced Pancreatic CarcinomaMetastatic Pancreatic Carcinoma+5 more
Mayo Clinic 13
Not applicableWithdrawnNCT04511793
What this trial is testing

Hepatic Artery Infusion (HAI) Program at Duke University

Who this might be right for
Metastatic Colon CancerLiver CancerIntrahepatic Cholangiocarcinoma
Michael Lidsky, M.D.
Not applicableStudy completedNCT03003078
What this trial is testing

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane

Who this might be right for
Unresectable Locally Advanced Pancreatic Carcinoma
OncoSil Medical Limited 50
Early research (Phase 1)Study completedNCT01131689
What this trial is testing

Trial of S-1 in Combination With Sorafenib for Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Samsung Medical Center 20
Large-scale testing (Phase 3)Looking for participantsNCT07062263
What this trial is testing

Trastuzumab Plus Chemotherapy vs Chemotherapy Alone in First-line HER2 Positive Advanced Biliary Tract Cancer Patients

Who this might be right for
Biliary Tract CancerHER2-positive CancerAdvanced Cancer+2 more
Tata Memorial Centre 220
Not applicableLooking for participantsNCT07377487
What this trial is testing

TheraSphere Japan Pre-Market Study

Who this might be right for
Liver Neoplasms
Boston Scientific Corporation 51
Early research (Phase 1)Study completedNCT03291938
What this trial is testing

IACS-010759 in Advanced Cancers

Who this might be right for
Advanced Malignant Solid NeoplasmAnatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+22 more
M.D. Anderson Cancer Center 29
Early research (Phase 1)Study completedNCT01325558
What this trial is testing

ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Locally Advanced Malignant NeoplasmMalignant Solid Tumour
Altor BioScience 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05627635
What this trial is testing

FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal AdenocarcinomaMetastatic Microsatellite Stable Colorectal Carcinoma+4 more
City of Hope Medical Center 20
Early research (Phase 1)Study completedNCT02903914
What this trial is testing

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic CancerSolid TumorsColorectal Cancer (CRC)+7 more
Incyte Corporation 260
Testing effectiveness (Phase 2)WithdrawnNCT00386516
What this trial is testing

Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer

Who this might be right for
Cancer of the Bile DuctGallbladder Cancer
Galectin Therapeutics Inc.
Large-scale testing (Phase 3)UnknownNCT05544253
What this trial is testing

Safety and Efficacy of Mitomycin C-based HIPEC After srHCC and PM of HCC

Who this might be right for
Hepatocellular CarcinomaPeritoneal MetastasisHyperthymic+1 more
West China Hospital 68
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07836712
What this trial is testing

Multiple Adjunct Therapies to Improve Immunotherapy Treatment in Patients With Locally Advanced or Metastatic Melanoma or Advanced Hepatocellular Cancer

Who this might be right for
Advanced Hepatocellular CarcinomaAdvanced MelanomaLocally Advanced Melanoma+3 more
University of Southern California 46
Not applicableUnknownNCT04504565
What this trial is testing

99m Tc-3PRGD2 SPECT/CT Imaging in the Diagnosis of Lymph Node Metastasis of Esophageal Carcinoma

Who this might be right for
Esophageal CancerLymph Node MetastasesDiagnoses Disease
Fifth Affiliated Hospital, Sun Yat-Sen University 30
Early research (Phase 1)UnknownNCT01266707
What this trial is testing

Antiangiogenic Peptide Vaccine Therapy in Treating Patient With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fukushima Medical University 9
Early research (Phase 1)Ended earlyNCT01552434
What this trial is testing

Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease

Who this might be right for
Advanced Malignant NeoplasmCastleman DiseaseDigestive System Carcinoma+36 more
M.D. Anderson Cancer Center 154
Not applicableUnknownNCT01892072
What this trial is testing

VEGF Signaling Promotes Cell Growth and Metastasis in Hepatocellular Carcinoma in a VEGF Receptor Mediated Pathway

Who this might be right for
Hepatocellular Carcinoma
First Affiliated Hospital, Sun Yat-Sen University 50
Not applicableActive Not RecruitingNCT04736121
What this trial is testing

Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients

Who this might be right for
Unresectable Hepatocellular CarcinomaBCLC Stage A Hepatocellular CarcinomaBCLC Stage B Hepatocellular Carcinoma+1 more
Sirtex Medical 100
Testing effectiveness (Phase 2)WithdrawnNCT06730100
What this trial is testing

CBX-12 for the Treatment of Metastatic Chemotherapy-Refractory Microsatellite Stable Colorectal Cancer

Who this might be right for
Metastatic Mismatch Repair Proficient Colorectal CarcinomaRefractory Mismatch Repair Proficient Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8
National Cancer Institute (NCI)
Next Page